ADORA3 and neoplasm: Pharmacological studies, using antagonists to the different adenosine receptors, revealed that A3AR plays a key role in the adenosine-induced inhibition of tumour cell proliferation, simultaneously stimulating bone marrow cell growth (Fishman et al, 2000a, 2000b; Bar-Yehuda et al, 2001).